- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Trump admin launches national security probe into chip, drug imports
By Craig Nigrelli (Anchor/Reporter), Shea Taylor (Producer), Kaleb Gillespie (Video Editor)
- The Trump administration opened national security investigations into foreign-made semiconductors, chipmaking tools and pharmaceuticals, potentially setting up new tariffs. The Commerce Department cited Section 232 and invited public input over a 21-day comment period.
- Officials said they aim to reduce supply chain risks and boost domestic production.
- Industry groups warned tariffs could raise costs and disrupt supply without phased implementation or exemptions.
Full Story
The Trump administration launched national security investigations into imports of semiconductors, chipmaking equipment and pharmaceutical products. The probes set the stage for potential new tariffs. The Commerce Department disclosed the probes in Federal Register notices on Monday, April 14, citing Section 232 of the Trade Expansion Act of 1962, which allows tariffs based on national security grounds.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn moreBias Summary
- The Trump administration has commenced investigations into imports of pharmaceuticals and semiconductors, aiming to impose tariffs based on national security, as noted in notices published on the Federal Register.
- A public comment period of 21 days will follow the announcements regarding these sector investigations, according to the filings set for release on Wednesday.
- John Murphy III, CEO of the Association for Accessible Medicines, warned that tariffs could worsen drug shortages and reduce patient access, stating, "Tariffs will only amplify the problems that already exist in the U.S. market for affordable medicines."
- President Donald Trump confirmed plans to apply pharmaceutical tariffs, declaring, "We need to make our own drugs."
- No summary available because of a lack of coverage.
- President Donald Trump is entering a new phase of tariffs targeting tech products and pharmaceuticals as part of his trade war with China.
- Customs and Border Protection announced 20 temporary tariff exemptions for items like smartphones and semiconductors entering the U.S.
- Commerce Secretary Howard Lutnick confirmed that the tariff exemptions are temporary while preparing sector-specific tariffs.
- Economists and executives warn that U.S. consumers will face increased costs from these tariffs as businesses pass on expenses.
Bias Comparison
Bias Distribution
Left
Right
Untracked Bias
Officials aim to assess whether U.S. reliance on foreign-made chips and drugs poses risks to domestic supply and national defense. The investigations also seek public comment within a 21-day period. Commerce Secretary Howard Lutnick said the administration may implement new tariffs within one to two months.

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.
Point phone camera here
What products are under review?
The probe into semiconductors covers silicon wafers, chip components, chipmaking equipment and downstream goods that contain chips, including vehicles, smartphones and appliances. Officials also plan to examine pharmaceuticals, active ingredients and derivative medical products.
Although President Donald Trump temporarily paused broad reciprocal tariffs on Wednesday, April 9, the administration clarified that electronics, semiconductors and pharmaceuticals would face separate duties under the Section 232 process.
What impact could these tariffs have on supply chains?
The administration said the new measures are intended to strengthen domestic manufacturing. However, drugmakers and tech companies warned that immediate tariffs could increase costs, trigger shortages and disrupt production. Industry representatives urged the administration to phase in tariffs gradually and consider carve-outs.
Commerce officials said they would study the feasibility of increasing domestic capacity and evaluate how foreign manufacturing, assembly and packaging affect the U.S.’s ability to meet demand.
How does this fit into Trump’s broader trade agenda?
Since returning to the White House in January, Trump has escalated the use of tariffs to protect critical sectors. Previous 232 probes led to 25% tariffs on steel, aluminum and automotive products. The administration recently excluded smartphones and computers from its steep 125% reciprocal tariffs but suggested those exemptions are temporary.
The U.S. began collecting a baseline 10% tariff on most imports on April 5. Trump said he may delay penalties on the auto industry to give manufacturers time to shift production from overseas to domestic facilities.
Get up to speed on the stories leading the day every weekday morning. Sign up for the newsletter today!
Learn more about our emails. Unsubscribe anytime.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
How have global manufacturers responded?
Taiwan Semiconductor Manufacturing Co. recently announced a $100 billion expansion of its U.S. investments. Nvidia revealed plans to build AI supercomputer factories entirely in the U.S. These efforts reflect broader U.S. policy goals established by the $280 billion CHIPS and Science Act to reduce dependence on foreign technology.
The pharmaceutical industry, with production networks spanning Europe, Asia and the U.S., cautioned that reshoring supply chains would require major long-term investment. Analysts expect announcements on semiconductor and drug tariffs as early as mid-May.
[craig nigrelli]
THE TRUMP ADMINISTRATION IS TAKING THE NEXT STEPS TOWARD IMPOSING MORE TARIFFS ON KEY ITEMS — BY LAUNCHING INVESTIGATIONS INTO IMPORTS OF COMPUTER CHIPS, CHIP-MAKING EQUIPMENT, AS WELL AS PHARMACEUTICALS.
IN NOTICES POSTED TO THE FEDERAL REGISTER LATE MONDAY — THE COMMERCE DEPARTMENT SAID IT’S INVESTIGATING **HOW** IMPORTS OF COMPUTER CHIPS, EQUIPMENT TO MAKE THEM AND PRODUCTS THAT CONTAIN THEM — WHICH INCLUDE MANY DAILY NECESSITIES SUCH AS CARS, REFRIGERATORS AND SMART PHONES, — AFFECT NATIONAL SECURITY.
SECTION 2-32 OF THE TRADE EXPANSION ACT OF 19-62 PERMITS THE PRESIDENT TO ORDER TARIFFS FOR THE SAKE OF NATIONAL SECURITY.
ALTHOUGH PRESIDENT TRUMP PAUSED MOST OF HIS BIGGEST TARIFF INCREASES LAST WEEK FOR 90 DAYS, EXCLUDING IMPORTS FROM CHINA, HE HAS SAID HE STILL PLANS ON IMPOSING TARIFFS ON PHARMACEUTICAL DRUGS, LUMBER, COPPER AND COMPUTER CHIPS.
THE COMMERCE DEPARTMENT’S INVESTIGATION IS TO ASSESS WHETHER THE U-S CAN MEET ITS OWN DEMAND FOR COMPUTER CHIPS AND THE ROLE OF FOREIGN MANUFACTURING, ASSEMBLY, TESTING AND PACKAGING IN MEETING THOSE NEEDS.
MEANWHILE, DONALD TRUMP’S TOP ECONOMIC ADVISER SAID MONDAY THE U-S IS CLOSE TO DEALS WITH MORE THAN 10 TRADING PARTNERS OVER THE CURRENT TARIFFS THAT ARE ON-HOLD.
AND THE PRESIDENT HIMSELF SUGGESTED HE **MIGHT** TEMPORARILY EXEMPT THE AUTO INDUSTRY FROM TARIFFS HE PREVIOUSLY IMPOSED — TO GIVE CARMAKERS TIME TO OVERHAUL THEIR COMPLEX SUPPLY CHAINS, SAYING THEY “NEED A LITTLE BIT OF TIME” TO RELOCATE PRODUCTION FROM CANADA, MEXICO AND OTHER PARTS OF THE WORLD, TO THE UNITED STATES.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn moreBias Summary
- The Trump administration has commenced investigations into imports of pharmaceuticals and semiconductors, aiming to impose tariffs based on national security, as noted in notices published on the Federal Register.
- A public comment period of 21 days will follow the announcements regarding these sector investigations, according to the filings set for release on Wednesday.
- John Murphy III, CEO of the Association for Accessible Medicines, warned that tariffs could worsen drug shortages and reduce patient access, stating, "Tariffs will only amplify the problems that already exist in the U.S. market for affordable medicines."
- President Donald Trump confirmed plans to apply pharmaceutical tariffs, declaring, "We need to make our own drugs."
- No summary available because of a lack of coverage.
- President Donald Trump is entering a new phase of tariffs targeting tech products and pharmaceuticals as part of his trade war with China.
- Customs and Border Protection announced 20 temporary tariff exemptions for items like smartphones and semiconductors entering the U.S.
- Commerce Secretary Howard Lutnick confirmed that the tariff exemptions are temporary while preparing sector-specific tariffs.
- Economists and executives warn that U.S. consumers will face increased costs from these tariffs as businesses pass on expenses.
Bias Comparison
Bias Distribution
Left
Right
Untracked Bias
Straight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
MOST POPULAR
-
MARCO BELLO/AFP via Getty Images
Bondi rescinds journalist protections amid focus on government leaks
ReadFriday -
Mario Tama/Getty Images
Paramount, CBS scrap DEI initiatives after lawsuit settlement
Watch 2:35Friday -
Getty Images
CA proposes bill requiring overnight parking at colleges for homeless students
Watch 3:00Friday -
Getty Images
Tariff price increases aren’t really inflation: Former Fed president
Watch 11:24Friday